Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
David Carpenter, Pharm.D.
Evecxia Therapeutics, Inc.
Poster(s):
(M0930-11-73) Formulation Optimization of EVX-101, a Novel Gastro-Retentive Prolonged-Release 5-HTP/Low-Dose Carbidopa Tablet
Monday, October 23, 2023
9:30 AM – 10:30 AM
ET